High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases-Reference-Cited by-同舟云学术

High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases

Published:2013-11-01 Issue:5 Volume:27 Page:731-739
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Jang Sejin,Chun Sung-Min,Hong Seoung-Mo,Sung Chang Ohk,Park Hosub,Kang Hyo Jeong,Kim Kyu-pyo,Lee Young Joo,Yu Eunsil

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2013194.pdf

Reference31 articles.

1. Yamamoto M, Ariizumi S . Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today 2011;41:896–902.

2. Guglielmi A, Ruzzenente A, Campagnaro T et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009;33:1247–1254.

3. Li YY, Li H, Lv P et al. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg 2011;15:608–613.

4. Gwak GY, Yoon JH, Shin CM et al. Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas. J Cancer Res Clin Oncol 2005;131:649–652.

5. Andersen JB, Spee B, Blechacz BR et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 2012;142:1021–1031 e1015.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology;Translational Oncology;2022-12

2. Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma;Pathology - Research and Practice;2022-04

3. Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review;World Journal of Gastrointestinal Oncology;2022-03-15

4. Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials;Expert Opinion on Investigational Drugs;2021-08-22

5. The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma;International Journal of Molecular Sciences;2021-03-23